中文 | English
Return
Total: 229 , 1/23
Show Home Prev Next End page: GO
Author:( Wenjing YANG)

1.Effect of miR-211 on proliferation and cell cycle related proteins of epithelial ovarian cancer cell line HO8910

Lu WANG ; Wenjing YANG

Chinese Journal of Immunology 2017;33(2):264-267

2.Clinical research progression of anorectal malignant melanoma

Wenjing YANG ; Yaoping LI

Journal of International Oncology 2013;(5):366-369

3.Effect of Dysbiosis of Intestinal Microbiota in Inflammatory Bowel Disease

Wenjing YANG ; Zhanju LIU

Chinese Journal of Gastroenterology 2015;(11):691-694

4.Effect of C-typenatriuretic peptide on paraquat-induced pulmonary fibrosis in mice

Chen YANG ; Wenjing ZHAO ; Tianli MENG

Chinese Journal of Anesthesiology 2016;36(7):890-892

5.Research progress of the small molecule covalent inhibitors.

Bo YANG ; Wenjing WANG ; Linli LI

Acta Pharmaceutica Sinica 2014;49(2):158-65

6.A survey of the current situation of English learning anxiety of TCM majors and its solution

Xiangguo KONG ; Yang DING ; Wenjing DU

Chinese Journal of Medical Education Research 2012;11(9):970-973

7.Causes of fever in systemic lupus erythematosus: a retrospective study of 487 hospitalized patients

Wenjing ZHOU ; Ting ZENG ; Chengde YANG

Chinese Journal of Rheumatology 2008;12(11):757-761

8.Autophagy-related gene Beclin-1 expression in neuron-like differentiation of human bone marrow mesenchymal stem cells

Yi YANG ; Wenjing DING ; Wanli DONG

Chinese Journal of Tissue Engineering Research 2014;(6):841-846

9.Effects of naringin on growth and COX-2 expressions in human cervical cancer HeLa cell line

Wenjing YANG ; Lu WANG ; Rui SUN

Chinese Journal of Immunology 2016;32(8):1200-1203

10.Mechanism of thiocoraline combination with cisplatin on promoting apoptosis of cervical cancer cell line c4-1 and Hela

Hongling DONG ; Ping ZHOU ; Wenjing YANG

Chinese Journal of Immunology 2017;33(1):99-102

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 229 , 1/23 Show Home Prev Next End page: GO